Case report: complete pathologic response to neoadjuvant ensartinib in locally advanced, ALK-positive lung squamous cell carcinoma - Quiz - MDSpire

Case report: complete pathologic response to neoadjuvant ensartinib in locally advanced, ALK-positive lung squamous cell carcinoma

  • By

  • Yingyu Yang

  • Junkai Zhang

  • Zhirun Xie

  • Sirui Zhang

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Case report: complete pathologic response to neoadjuvant ensartinib in locally advanced, ALK-positive lung squamous cell carcinoma

  • by Yingyu Yang, Junkai Zhang, Zhirun Xie, Sirui Zhang

  • May 25, 2026

Related Content

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Management of toxicities from antibody – drug conjugates in breast cancer

Potential targets for boron transport in boron neutron capture therapy